📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Circulating tumour DNA analyses reveal novel resistance mechanisms to CDK inhibition in metastatic breast cancer. (2018)

First Author: Abbosh C

Attributed to: Lethal renal cell carcinoma sub-clones: Defining mechanisms of tumour evolution, treatment resistance and immune escape. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/annonc/mdy017

PubMed Identifier: 29351578

Publication URI: http://europepmc.org/abstract/MED/29351578

Type: Journal Article/Review

Volume: 29

Parent Publication: Annals of oncology : official journal of the European Society for Medical Oncology

Issue: 3

ISSN: 0923-7534